This Article Full Text Full Text (PDF) All Versions of this Article: 200302-278OCv1 169/5/615    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by O'Donnell, A. R. Articles by Le Souëf, P. N. Search for Related Content PubMed PubMed Citation Articles by O'Donnell, A. R. Articles by Le Souëf, P. N.

Age-specific Relationship between CD14 and Atopy in a Cohort Assessed from Age 8 to 25 Years

Department of Paediatrics, University of Western Australia, Children's Hospital Medical Centre, Perth; and The Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia

Correspondence and requests for reprints should be addressed to Peter N. Le Souëf, M.D., F.R.A.C.P., University Department of Paediatrics, Children's Hospital Medical Centre, Princess Margaret Hospital, G.P.O. Box D184, Perth, WA, Australia 6001. E-mail: peterles{at}ichr.uwa.edu.au

CD14 influences postnatal switching of T helper cell responses. CD14 C-159T has been associated with altered CD14 and IgE levels in cross-sectional studies. Identifying whether associations vary with age requires data from children of the same age followed longitudinally over many years. In this study, an unselected population with extensive longitudinal data was used to test the hypothesis that CD14 C-159T was associated with early-onset atopy. A total of 305 subjects were assessed on up to seven occasions between ages 8 and 25 years by questionnaire, histamine challenge, and skin prick test. For atopy, airway hyperresponsiveness (AHR), and wheeze, each subject was classified as having early onset, late onset, or no disease onset during follow-up. Compared with subjects with -159CT and -159TT, subjects with -159CC had an odds ratio of 2.2 (p = 0.018) for early-onset atopy and an odds ratio of 2.6 (p = 0.019) for early-onset AHR. Cross-sectional analysis showed increased prevalence of -159CC in subjects with atopy and AHR in childhood but not adulthood. These data suggest that the influence of CD14 -159C on the atopic phenotype may be age specific, exerting an effect during midchildhood, which is no longer apparent by early adulthood.

Key Words: longitudinal • gene • polymorphism • asthma

This article has been cited by other articles:

				R. W. B. Bottema, N. E. Reijmerink, M. Kerkhof, G. H. Koppelman, F. F. Stelma, J. Gerritsen, C. Thijs, B. Brunekreef, C. P. van Schayck, and D. S. Postma Interleukin 13, CD14, pet and tobacco smoke influence atopy in three Dutch cohorts: the allergenic study Eur. Respir. J., September 1, 2008; 32(3): 593 - 602. [Abstract] [Full Text] [PDF]

				T. Kallinich, K. C. Beier, U. Wahn, P. Stock, and E. Hamelmann T-cell co-stimulatory molecules: their role in allergic immune reactions Eur. Respir. J., June 1, 2007; 29(6): 1246 - 1255. [Abstract] [Full Text] [PDF]

				F. D. Martinez Genes, environments, development and asthma: a reappraisal Eur. Respir. J., January 1, 2007; 29(1): 179 - 184. [Abstract] [Full Text] [PDF]

				A. El-Ekiaby, L. Brianas, M. E. Skowronski, A. J. Coreno, G. Galan, F. J. Kaeberlein, R. E. Seitz, K. D. Villaba, H. Dickey-White, and E. R. McFadden Jr. Impact of Race on the Severity of Acute Episodes of Asthma and Adrenergic Responsiveness Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 508 - 513. [Abstract] [Full Text] [PDF]

				A. Simpson, S. L. John, F. Jury, R. Niven, A. Woodcock, W. E. R. Ollier, and A. Custovic Endotoxin Exposure, CD14, and Allergic Disease: An Interaction between Genes and the Environment Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 386 - 392. [Abstract] [Full Text] [PDF]

				S. P. Wiertsema, S.-K. Khoo, G. Baynam, R. H. Veenhoven, I. A. Laing, G. A. Zielhuis, G. T. Rijkers, J. Goldblatt, P. N. LeSouef, and E. A. M. Sanders Association of CD14 Promoter Polymorphism with Otitis Media and Pneumococcal Vaccine Responses. Clin. Vaccine Immunol., August 1, 2006; 13(8): 892 - 897. [Abstract] [Full Text] [PDF]

				M H Brutsche, S H Downs, C Schindler, M W Gerbase, J Schwartz, M Frey, E W Russi, U Ackermann-Liebrich, P Leuenberger, and for the SAPALDIA Team Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study Thorax, August 1, 2006; 61(8): 671 - 677. [Abstract] [Full Text] [PDF]

				A. Bush Update in pediatrics 2005. Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 585 - 592. [Full Text] [PDF]

				A. C. Martin, I. A. Laing, S.-K. Khoo, G. Zhang, K. Rueter, L. Teoh, S. Taheri, C. M. Hayden, G. C. Geelhoed, J. Goldblatt, et al. Acute Asthma in Children: Relationships among CD14 and CC16 Genotypes, Plasma Levels, and Severity Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 617 - 622. [Abstract] [Full Text] [PDF]

				J. Shi, N. L. A. Misso, D. L. Duffy, B. Bradley, R. Beard, P. J. Thompson, and M-A. Kedda Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy Eur. Respir. J., August 1, 2005; 26(2): 249 - 256. [Abstract] [Full Text] [PDF]

				S. Choudhry, P. C. Avila, S. Nazario, N. Ung, J. Kho, J. R. Rodriguez-Santana, J. Casal, H.-J. Tsai, A. Torres, E. Ziv, et al. CD14 Tobacco Gene-Environment Interaction Modifies Asthma Severity and Immunoglobulin E Levels in Latinos with Asthma Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 173 - 182. [Abstract] [Full Text] [PDF]

				A. Bush, F. Accurso, W. MacNee, S. C. Lazarus, and E. Abraham Cystic Fibrosis, Pediatrics, Control of Breathing, Pulmonary Physiology and Anatomy, and Surfactant Biology in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 545 - 553. [Full Text] [PDF]

				M. N. Blumenthal New Thoughts Regarding the Genetics of Atopy Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 555 - 556. [Full Text] [PDF]